Geng Y, Xie X, Wang Y, Jiang D X, Zhang W, Zhang Z L, Zhao Y
Department of Rheumatology and Clinical Immunology, Peking University First Hospital, Beijing 100034, China.
Department of Rheumatology and Clinical Immunology, the Second Xiangya Hospital of Central South University, Changsha 410011, China.
Zhonghua Nei Ke Za Zhi. 2022 Jan 1;61(1):51-59. doi: 10.3760/cma.j.cn112138-20210616-00426.
Rheumatoid arthritis (RA) is an autoimmune disease characterized by synovial inflammation of the joints with high risk of disability. In recent years, remarkable progress has been made towards the diagnosis and treatment of RA, and the international RA guidelines have been also kept updated. Nevertheless, there are many challenges in China, especially inadequate number of rheumatologists and insufficient experience in the diagnosis and treatment of RA. Therefore, Chinese Rheumatology Association drafted the standardized diagnosis and treatment of RA based on the available evidence, so as to improve the management of RA patients in China.
类风湿关节炎(RA)是一种自身免疫性疾病,其特征为关节滑膜炎症,具有较高的致残风险。近年来,RA的诊断和治疗取得了显著进展,国际RA指南也不断更新。然而,中国仍面临诸多挑战,尤其是风湿病学家数量不足,以及RA诊断和治疗经验欠缺。因此,中华医学会风湿病学分会根据现有证据起草了RA的规范化诊断和治疗方案,以改善中国RA患者的管理。